Neonatal Applications of Heliox: A Practical Review
- PMID: 35359907
- PMCID: PMC8960277
- DOI: 10.3389/fped.2022.855050
Neonatal Applications of Heliox: A Practical Review
Abstract
Heliox is a mixture of helium and oxygen that may be utilized as an alternative to air-oxygen during the ventilatory support in the neonate. Special physical properties of Heliox, particularly low density, allow for improved gas flow and diffusion. First reports of Heliox use in the pediatric population were published in 1930s; however, this therapy has never gained widespread popularity despite its described beneficial effects. Historically, this was largely due to technical challenges associated with Heliox ventilation that significantly limited its use and realization of large-scale clinical trials. However, nowadays several commercially available ventilators allow easy and safe ventilation with both conventional and non-invasive modes. In the era of minimally invasive respiratory interventions in the newborn Heliox could be seen as a therapy that may potentially decrease the risk of non-invasive ventilation failure. This review presents pathophysiologic rationale for the use of Heliox in the newborn, and summarizes available data regarding applications of Heliox in the setting of neonatal intensive care unit based on clinical studies and findings from animal models. Mechanisms of action and practical aspects of Heliox delivery are thoroughly discussed. Finally, future research directions for neonatal use of Heliox are proposed.
Keywords: heliox; helium; mechanical ventilation; neonate; newborn; non-invasive respiratory support; respiratory distress; respiratory failure.
Copyright © 2022 Szczapa, Kwapień and Merritt.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
The potential of heliox as a therapy for acute respiratory distress syndrome in adults and children: a descriptive review.Respiration. 2015;89(2):166-74. doi: 10.1159/000369472. Epub 2015 Jan 31. Respiration. 2015. PMID: 25662070 Review.
-
Effects of heliox and non-invasive neurally adjusted ventilatory assist (NIV-NAVA) in preterm infants.Sci Rep. 2021 Aug 4;11(1):15778. doi: 10.1038/s41598-021-95444-2. Sci Rep. 2021. PMID: 34349223 Free PMC article.
-
Use of heliox in the management of neonates with meconium aspiration syndrome.Neonatology. 2011;100(3):265-70. doi: 10.1159/000327531. Epub 2011 Jun 23. Neonatology. 2011. PMID: 21701217 Clinical Trial.
-
[Heliox augmented mechanical ventilation in the treatment of premature infants with respiratory distress syndrome].Ginekol Pol. 2014 Dec;85(12):939-43. doi: 10.17772/gp/1886. Ginekol Pol. 2014. PMID: 25669064 Polish.
-
Heliox administration in the pediatric intensive care unit: an evidence-based review.Pediatr Crit Care Med. 2005 Mar;6(2):204-11. doi: 10.1097/01.PCC.0000154946.62733.94. Pediatr Crit Care Med. 2005. PMID: 15730610 Review.
Cited by
-
Effectiveness of ultra-/very-high-frequency oscillations combined with helium-oxygen gas mixture in a rabbit model.Sci Rep. 2024 Oct 29;14(1):25945. doi: 10.1038/s41598-024-77703-0. Sci Rep. 2024. PMID: 39472706 Free PMC article.
-
Heliox preconditioning exerts pulmonary protection effects on neonatal acute respiratory distress syndrome by inhibiting oxidative stress and apoptosis.Front Pharmacol. 2025 Aug 15;16:1621190. doi: 10.3389/fphar.2025.1621190. eCollection 2025. Front Pharmacol. 2025. PMID: 40894209 Free PMC article.
-
Progress in the clinical application of heliox.Med Gas Res. 2025 Dec 1;15(4):546-547. doi: 10.4103/mgr.MEDGASRES-D-25-00026. Epub 2025 Apr 29. Med Gas Res. 2025. PMID: 40300891 Free PMC article. No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources